Li Z, Zhang X, Zhao Y, Lu L, et al. Imatinib dose reduction after major molecular response in chronic-phase chronic myeloid leukemia. Cancer 2024 Sep 21. doi: 10.1002/cncr.35565.
PMID: 39305107